Aegerion Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - August 10, 2010

Attached files

file filename
S-1 - FORM S-1 - Aegerion Pharmaceuticals, Inc.ds1.htm
EX-10.9 - LOAN AND SECURITY AGREEMENT WITH HERCULES TECHNOLOGY GROWTH CAPITAL, INC. - Aegerion Pharmaceuticals, Inc.dex109.htm
EX-10.7 - LICENSE AGREEMENT WITH BAYER HEALTHCARE AG - Aegerion Pharmaceuticals, Inc.dex107.htm
EX-10.6 - PATENT LICENSE AGREEMENT WITH UNIVERSITY OF PENNSYLVANIA - Aegerion Pharmaceuticals, Inc.dex106.htm
EX-10.3 - AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - Aegerion Pharmaceuticals, Inc.dex103.htm
EX-10.1 - 2006 STOCK OPTION AND GRANT PLAN - Aegerion Pharmaceuticals, Inc.dex101.htm
EX-10.8 - SUBLEASE AGREEMENT WITH TIBBETT & BRITTEN GROUP NORTH AMERICA, INC. - Aegerion Pharmaceuticals, Inc.dex108.htm
EX-10.10 - SECURED PROMISSORY NOTE - Aegerion Pharmaceuticals, Inc.dex1010.htm
EX-10.11 - AMENDED AND RESTATED WARRANT AGREEMENT - Aegerion Pharmaceuticals, Inc.dex1011.htm
EX-10.14 - THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT - Aegerion Pharmaceuticals, Inc.dex1014.htm
EX-10.15 - FORM OF NOTE ISSUED UNDER THE THIRD AMENDED & RESTATED NOTE PURCHASE AGREEMENT - Aegerion Pharmaceuticals, Inc.dex1015.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated August 9, 2010, in the Registration Statement (Form S-1) and related Prospectus of Aegerion Pharmaceuticals, Inc. for the registration of shares of its common stock, to be filed with the Securities and Exchange Commission on or about August 9, 2010.

/s/ Ernst & Young LLP

MetroPark, New Jersey

August 9, 2010

Aegerion Pharmaceuticals, Inc. Reports

Also read